Stock NEU NEUREN PHARMACEUTICALS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Neuren Pharmaceuticals Limited

Equities

NEU

NZNEUE0001S8

Delayed Australian S.E.
Other stock markets
 12:35:44 2024-05-01 am EDT 		5-day change 1st Jan Change
19.12 AUD -0.42% Intraday chart for Neuren Pharmaceuticals Limited -0.93% -23.43%
Apr. 24 Neuren Pharmaceuticals Posts AU$243 Million Cash, Short-Term Investments MT
Apr. 23 Neuren Pharmaceuticals' Medication Secures Priority Review from Health Canada MT

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Argenica Therapeutics Appoints Nonexecutive Chair
MT
Neuren Pharmaceuticals Appoints Joe Basile to Board of Directors
CI
Neuren Pharmaceuticals Appoints US-Based Medical Chief
MT
Neuren Pharmaceuticals Appoints Liza A. Squires as Chief Medical Officer in United States
CI
Neuren Pharmaceuticals Limited Appoints Jon Pilcher as Managing Director
CI
Neuren Pharmaceuticals Limited Appoints Lauren Frazer as Chief Financial Officer, Effective August 1, 2020
CI
Neuren Pharmaceuticals Limited Appoints Lauren Frazer as Company Secretary, Effective August 1, 2020
CI
Neuren Pharmaceuticals Limited Announces Changes to Leadership Team
CI
Neuren Pharmaceuticals Announces the Appointment of Jon Pilcher as Chief Executive Officer
CI
Larry Glass to Retire from the Neuren Pharmaceuticals Limited's Board of Directors on 31 December 2018
CI
Neuren Announces New Appointments to the Board of Directors
CI
Neuren Pharmaceuticals Announces Bruce Hancox's Retirement
CI
Neuren Pharmaceuticals Limited Appoints Clive Blower as Vice-President of Product Development and Technical Affairs
CI
Neuren Announces Management Changes
CI
Neuren Pharmaceuticals Limited to Appoint Jon Pilcher as Chief Financial Officer and Company Secretary, Effective August 19, 2013
CI
Neuren Pharmaceuticals Limited Announces the Cessation of John Douglas Wilson as Director
CI
Neuren Pharmaceuticals Limited Announces Cessation of Robin Lance Congreve as Director
CI
Neuren Pharmaceuticals Limited Appoints Richard Treagus as an Executive Chairman of the Board
CI
Neuren Pharmaceuticals Limited Appoints Nancy E. Jones as Senior Director of Clinical Development and Medical Affairs
CI
Neuren Pharmaceuticals Limited Appoints Joseph Horrigan as VP Clinical and Medical Affairs
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NEU Stock
  4. News Neuren Pharmaceuticals Limited
  5. Insiders